1 month Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue Estimates Zacks
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 46.43% and 230.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X